BioUrbis: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
BioUrbis
Largest movements
- Current investments -€466,980
no longer reported in 2025 (was €466,980)
- Cash +€96,492
up €96,492 (+2.3%), from €4.2m to €4.3m
mainly Current investments (+€466,980) and Net result for the year (+€40,473)
- Other debts -€330,000
no longer reported in 2025 (was €330,000)
- Debts after one year -€52,749
no longer reported in 2025 (was €52,749)
- Financial income -€614,998
down €614,998 (-83.9%), from €732,766 to €117,768
- Financial charges +€63,607
up €63,607 (+1204.8%), from €5,280 to €68,887
- Taxes -€36,000
down €36,000 (-90.0%), from €40,000 to €4,000
- Other operating charges -€5,379
down €5,379 (-82.2%), from €6,546 to €1,167
- Gross operating margin -€147
down €147 (-4.8%), from -€3,093 to -€3,241
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €4,663,392 | €4,304,862 | -€358,529 | -7.7% |
| Current assets | 29/58 | €4,663,392 | €4,304,862 | -€358,529 | -7.7% |
| Amounts receivable within one year | 40/41 | - | €11,958 | +€11,958 | |
| Other amounts receivable | 41 | - | €11,958 | +€11,958 | |
| Current investments | 50/53 | €466,980 | - | -€466,980 | |
| Cash at bank and in hand | 54/58 | €4,196,412 | €4,292,904 | +€96,492 | +2.3% |
| Total equity and liabilities | 10/49 | €4,663,392 | €4,304,862 | -€358,529 | -7.7% |
| Equity | 10/15 | €4,264,389 | €4,304,862 | +€40,473 | +0.9% |
| Contributions | 10/11 | €2,500,000 | €2,500,000 | = | 0.0% |
| Capital | 10 | €2,500,000 | €2,500,000 | = | 0.0% |
| Issued capital | 100 | €2,500,000 | €2,500,000 | = | 0.0% |
| Reserves | 13 | €1,764,000 | €1,804,000 | +€40,000 | +2.3% |
| Non-distributable reserves | 130/1 | €250,000 | €250,000 | = | 0.0% |
| Legal reserve | 130 | €250,000 | €250,000 | = | 0.0% |
| Distributable reserves | 133 | €1,514,000 | €1,554,000 | +€40,000 | +2.6% |
| Profit (loss) carried forward | 14 | €389 | €862 | +€473 | +121.7% |
| Amounts payable | 17/49 | €399,003 | - | -€399,003 | |
| Amounts payable after more than one year | 17 | €52,749 | - | -€52,749 | |
| Other amounts payable | 178/9 | €52,749 | - | -€52,749 | |
| Amounts payable within one year | 42/48 | €346,254 | - | -€346,254 | |
| Trade debts | 44 | €0 | - | = | |
| Suppliers | 440/4 | €0 | - | = | |
| Taxes, remuneration and social security | 45 | €16,254 | - | -€16,254 | |
| Taxes | 450/3 | €16,254 | - | -€16,254 | |
| Other amounts payable | 47/48 | €330,000 | - | -€330,000 | |
| Other operating charges | 640/8 | €6,546 | €1,167 | -€5,379 | -82.2% |
| Gross operating margin | 9900 | -€3,093 | -€3,241 | -€147 | -4.8% |
| Operating profit (loss) | 9901 | -€9,639 | -€4,407 | +€5,232 | +54.3% |
| Financial income | 75/76B | €732,766 | €117,768 | -€614,998 | -83.9% |
| Recurring financial income | 75 | €732,766 | €117,768 | -€614,998 | -83.9% |
| Financial charges | 65/66B | €5,280 | €68,887 | +€63,607 | +1204.8% |
| Recurring financial charges | 65 | €5,280 | €68,887 | +€63,607 | +1204.8% |
| Profit (loss) for the period before taxes | 9903 | €717,848 | €44,473 | -€673,374 | -93.8% |
| Income taxes | 67/77 | €40,000 | €4,000 | -€36,000 | -90.0% |
| Profit (loss) for the period | 9904 | €677,848 | €40,473 | -€637,374 | -94.0% |
| Profit (loss) for the period to be appropriated | 9905 | €677,848 | €40,473 | -€637,374 | -94.0% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.